The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study

Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lancet neurology Jg. 17; H. 5; S. 434 - 444
Hauptverfasser:	van der Lee, Sven J, Wolters, Frank J, Ikram, M Kamran, Hofman, Albert, Ikram, M Arfan, Amin, Najaf, van Duijn, Cornelia M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Elsevier Ltd 01.05.2018 Elsevier Limited
Schlagworte:	Age Age of Onset Aged Aged, 80 and over Alzheimer Disease - epidemiology Alzheimer Disease - genetics Alzheimer's disease Apolipoprotein E Apolipoproteins E - genetics Blood pressure Cohort analysis Cohort Studies Dementia Dementia - epidemiology Dementia - genetics Dementia disorders Female Genetic diversity Genotypes Geriatrics Health risk assessment Humans Male Middle Aged Netherlands - epidemiology Neurodegenerative diseases Risk Assessment - statistics & numerical data Risk factors Studies Vitamin E Netherlands
ISSN:	1474-4422, 1474-4465, 1474-4465
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these variants and APOE on cumulative risk and age at onset of Alzheimer's disease and all-cause dementia. We studied incident dementia in cognitively healthy participants (aged >45 years) from the community-based Rotterdam Study, an ongoing prospective cohort study based in Rotterdam, the Netherlands, focusing on neurological, cardiovascular, endocrine, and ophthalmological disorders, and other diseases in elderly people. The Rotterdam Study comprises participants in three baseline cohorts (initiated in 1990, 2000, and 2006), who are re-invited to the research centre every 3–4 years, and continuously monitored by records from general practitioners and medical specialists. Cumulative incidence curves up to age 100 years were calculated for Alzheimer's disease and dementia, taking into account mortality as a competing event. These risk curves were stratified by APOE genotypes, tertiles of a weighted genetic risk score (GRS) of 23 Alzheimer's disease-associated genetic variants, and parental history of dementia. 12 255 of 14 926 participants (58·5% women) from the Rotterdam Study were included in this study. During a median follow-up of 11·0 years (IQR 4·9–15·9; 133 123 person years), 1609 participants developed dementia, of whom 1262 (78%) were classified as having Alzheimer's disease; 3310 people died of causes other than dementia. Both APOE and the GRS significantly modified the risks of Alzheimer's disease and dementia. There was evidence for a significant interaction between APOE genotypes and the GRS for the association with Alzheimer's disease (p=0·03) and dementia (p=0·04); the risk for carriers homozygous for APOE ε4 was modified most by the GRS. In carriers homozygous for APOE ε4, the difference between the high-risk tertile and the low-risk tertile by age 85 years was 27·0% for Alzheimer's disease (p=8·5 × 10−3) and 37·2% for dementia (p=2·2 × 10−4), which translates to a 7–10 year difference in age at onset. Comparing the risk extremes, which were carriers homozygous for APOE ε2 or heterozygous with one copy each of the ε2 and ε3 alleles in the low-risk tertile of the GRS versus carriers homozygous for APOE ε4 in the high-risk tertile of the GRS, the difference in risk by age 85 years was 58·6% (4·1% vs 62·7%; p=6·2 × 10−13) for Alzheimer's disease, and 70·3% (7·2% vs 77·5%; p=3·0 × 10−23) for dementia. These risk differences translate into an 18–29 years difference in age at onset for Alzheimer's disease and an 18–23 year difference in age at onset dementia. This difference becomes more pronounced when parental history of dementia is considered (difference in risk 83·8%; p=1·1 × 10−20). Common variants with small individual effects jointly modify the risk and age at onset of Alzheimer's disease and dementia, particularly in APOE ε4 carriers. These findings highlight the potential of common variants in determining Alzheimer's disease risk. None.
AbstractList	Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these variants and APOE on cumulative risk and age at onset of Alzheimer's disease and all-cause dementia.BACKGROUNDAlzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these variants and APOE on cumulative risk and age at onset of Alzheimer's disease and all-cause dementia.We studied incident dementia in cognitively healthy participants (aged >45 years) from the community-based Rotterdam Study, an ongoing prospective cohort study based in Rotterdam, the Netherlands, focusing on neurological, cardiovascular, endocrine, and ophthalmological disorders, and other diseases in elderly people. The Rotterdam Study comprises participants in three baseline cohorts (initiated in 1990, 2000, and 2006), who are re-invited to the research centre every 3-4 years, and continuously monitored by records from general practitioners and medical specialists. Cumulative incidence curves up to age 100 years were calculated for Alzheimer's disease and dementia, taking into account mortality as a competing event. These risk curves were stratified by APOE genotypes, tertiles of a weighted genetic risk score (GRS) of 23 Alzheimer's disease-associated genetic variants, and parental history of dementia.METHODSWe studied incident dementia in cognitively healthy participants (aged >45 years) from the community-based Rotterdam Study, an ongoing prospective cohort study based in Rotterdam, the Netherlands, focusing on neurological, cardiovascular, endocrine, and ophthalmological disorders, and other diseases in elderly people. The Rotterdam Study comprises participants in three baseline cohorts (initiated in 1990, 2000, and 2006), who are re-invited to the research centre every 3-4 years, and continuously monitored by records from general practitioners and medical specialists. Cumulative incidence curves up to age 100 years were calculated for Alzheimer's disease and dementia, taking into account mortality as a competing event. These risk curves were stratified by APOE genotypes, tertiles of a weighted genetic risk score (GRS) of 23 Alzheimer's disease-associated genetic variants, and parental history of dementia.12 255 of 14 926 participants (58·5% women) from the Rotterdam Study were included in this study. During a median follow-up of 11·0 years (IQR 4·9-15·9; 133 123 person years), 1609 participants developed dementia, of whom 1262 (78%) were classified as having Alzheimer's disease; 3310 people died of causes other than dementia. Both APOE and the GRS significantly modified the risks of Alzheimer's disease and dementia. There was evidence for a significant interaction between APOE genotypes and the GRS for the association with Alzheimer's disease (p=0·03) and dementia (p=0·04); the risk for carriers homozygous for APOE ε4 was modified most by the GRS. In carriers homozygous for APOE ε4, the difference between the high-risk tertile and the low-risk tertile by age 85 years was 27·0% for Alzheimer's disease (p=8·5 × 10-3) and 37·2% for dementia (p=2·2 × 10-4), which translates to a 7-10 year difference in age at onset. Comparing the risk extremes, which were carriers homozygous for APOE ε2 or heterozygous with one copy each of the ε2 and ε3 alleles in the low-risk tertile of the GRS versus carriers homozygous for APOE ε4 in the high-risk tertile of the GRS, the difference in risk by age 85 years was 58·6% (4·1% vs 62·7%; p=6·2 × 10-13) for Alzheimer's disease, and 70·3% (7·2% vs 77·5%; p=3·0 × 10-23) for dementia. These risk differences translate into an 18-29 years difference in age at onset for Alzheimer's disease and an 18-23 year difference in age at onset dementia. This difference becomes more pronounced when parental history of dementia is considered (difference in risk 83·8%; p=1·1 × 10-20).FINDINGS12 255 of 14 926 participants (58·5% women) from the Rotterdam Study were included in this study. During a median follow-up of 11·0 years (IQR 4·9-15·9; 133 123 person years), 1609 participants developed dementia, of whom 1262 (78%) were classified as having Alzheimer's disease; 3310 people died of causes other than dementia. Both APOE and the GRS significantly modified the risks of Alzheimer's disease and dementia. There was evidence for a significant interaction between APOE genotypes and the GRS for the association with Alzheimer's disease (p=0·03) and dementia (p=0·04); the risk for carriers homozygous for APOE ε4 was modified most by the GRS. In carriers homozygous for APOE ε4, the difference between the high-risk tertile and the low-risk tertile by age 85 years was 27·0% for Alzheimer's disease (p=8·5 × 10-3) and 37·2% for dementia (p=2·2 × 10-4), which translates to a 7-10 year difference in age at onset. Comparing the risk extremes, which were carriers homozygous for APOE ε2 or heterozygous with one copy each of the ε2 and ε3 alleles in the low-risk tertile of the GRS versus carriers homozygous for APOE ε4 in the high-risk tertile of the GRS, the difference in risk by age 85 years was 58·6% (4·1% vs 62·7%; p=6·2 × 10-13) for Alzheimer's disease, and 70·3% (7·2% vs 77·5%; p=3·0 × 10-23) for dementia. These risk differences translate into an 18-29 years difference in age at onset for Alzheimer's disease and an 18-23 year difference in age at onset dementia. This difference becomes more pronounced when parental history of dementia is considered (difference in risk 83·8%; p=1·1 × 10-20).Common variants with small individual effects jointly modify the risk and age at onset of Alzheimer's disease and dementia, particularly in APOE ε4 carriers. These findings highlight the potential of common variants in determining Alzheimer's disease risk.INTERPRETATIONCommon variants with small individual effects jointly modify the risk and age at onset of Alzheimer's disease and dementia, particularly in APOE ε4 carriers. These findings highlight the potential of common variants in determining Alzheimer's disease risk.None.FUNDINGNone. Summary Background Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these variants and APOE on cumulative risk and age at onset of Alzheimer's disease and all-cause dementia. Methods We studied incident dementia in cognitively healthy participants (aged >45 years) from the community-based Rotterdam Study, an ongoing prospective cohort study based in Rotterdam, the Netherlands, focusing on neurological, cardiovascular, endocrine, and ophthalmological disorders, and other diseases in elderly people. The Rotterdam Study comprises participants in three baseline cohorts (initiated in 1990, 2000, and 2006), who are re-invited to the research centre every 3–4 years, and continuously monitored by records from general practitioners and medical specialists. Cumulative incidence curves up to age 100 years were calculated for Alzheimer's disease and dementia, taking into account mortality as a competing event. These risk curves were stratified by APOE genotypes, tertiles of a weighted genetic risk score (GRS) of 23 Alzheimer's disease-associated genetic variants, and parental history of dementia. Findings 12 255 of 14 926 participants (58·5% women) from the Rotterdam Study were included in this study. During a median follow-up of 11·0 years (IQR 4·9–15·9; 133 123 person years), 1609 participants developed dementia, of whom 1262 (78%) were classified as having Alzheimer's disease; 3310 people died of causes other than dementia. Both APOE and the GRS significantly modified the risks of Alzheimer's disease and dementia. There was evidence for a significant interaction between APOE genotypes and the GRS for the association with Alzheimer's disease (p=0·03) and dementia (p=0·04); the risk for carriers homozygous for APOE ε4 was modified most by the GRS. In carriers homozygous for APOE ε4, the difference between the high-risk tertile and the low-risk tertile by age 85 years was 27·0% for Alzheimer's disease (p=8·5 × 10−3) and 37·2% for dementia (p=2·2 × 10−4), which translates to a 7–10 year difference in age at onset. Comparing the risk extremes, which were carriers homozygous for APOE ε2 or heterozygous with one copy each of the ε2 and ε3 alleles in the low-risk tertile of the GRS versus carriers homozygous for APOE ε4 in the high-risk tertile of the GRS, the difference in risk by age 85 years was 58·6% (4·1% vs 62·7%; p=6·2 × 10−13) for Alzheimer's disease, and 70·3% (7·2% vs 77·5%; p=3·0 × 10−23) for dementia. These risk differences translate into an 18–29 years difference in age at onset for Alzheimer's disease and an 18–23 year difference in age at onset dementia. This difference becomes more pronounced when parental history of dementia is considered (difference in risk 83·8%; p=1·1 × 10−20). Interpretation Common variants with small individual effects jointly modify the risk and age at onset of Alzheimer's disease and dementia, particularly in APOE ε4 carriers. These findings highlight the potential of common variants in determining Alzheimer's disease risk. Funding None. Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these variants and APOE on cumulative risk and age at onset of Alzheimer's disease and all-cause dementia. We studied incident dementia in cognitively healthy participants (aged >45 years) from the community-based Rotterdam Study, an ongoing prospective cohort study based in Rotterdam, the Netherlands, focusing on neurological, cardiovascular, endocrine, and ophthalmological disorders, and other diseases in elderly people. The Rotterdam Study comprises participants in three baseline cohorts (initiated in 1990, 2000, and 2006), who are re-invited to the research centre every 3–4 years, and continuously monitored by records from general practitioners and medical specialists. Cumulative incidence curves up to age 100 years were calculated for Alzheimer's disease and dementia, taking into account mortality as a competing event. These risk curves were stratified by APOE genotypes, tertiles of a weighted genetic risk score (GRS) of 23 Alzheimer's disease-associated genetic variants, and parental history of dementia. 12 255 of 14 926 participants (58·5% women) from the Rotterdam Study were included in this study. During a median follow-up of 11·0 years (IQR 4·9–15·9; 133 123 person years), 1609 participants developed dementia, of whom 1262 (78%) were classified as having Alzheimer's disease; 3310 people died of causes other than dementia. Both APOE and the GRS significantly modified the risks of Alzheimer's disease and dementia. There was evidence for a significant interaction between APOE genotypes and the GRS for the association with Alzheimer's disease (p=0·03) and dementia (p=0·04); the risk for carriers homozygous for APOE ε4 was modified most by the GRS. In carriers homozygous for APOE ε4, the difference between the high-risk tertile and the low-risk tertile by age 85 years was 27·0% for Alzheimer's disease (p=8·5 × 10−3) and 37·2% for dementia (p=2·2 × 10−4), which translates to a 7–10 year difference in age at onset. Comparing the risk extremes, which were carriers homozygous for APOE ε2 or heterozygous with one copy each of the ε2 and ε3 alleles in the low-risk tertile of the GRS versus carriers homozygous for APOE ε4 in the high-risk tertile of the GRS, the difference in risk by age 85 years was 58·6% (4·1% vs 62·7%; p=6·2 × 10−13) for Alzheimer's disease, and 70·3% (7·2% vs 77·5%; p=3·0 × 10−23) for dementia. These risk differences translate into an 18–29 years difference in age at onset for Alzheimer's disease and an 18–23 year difference in age at onset dementia. This difference becomes more pronounced when parental history of dementia is considered (difference in risk 83·8%; p=1·1 × 10−20). Common variants with small individual effects jointly modify the risk and age at onset of Alzheimer's disease and dementia, particularly in APOE ε4 carriers. These findings highlight the potential of common variants in determining Alzheimer's disease risk. None. Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant of Alzheimer's disease, the APOE gene, 23 genetic variants have been associated with the disease. We assessed the effects of these variants and APOE on cumulative risk and age at onset of Alzheimer's disease and all-cause dementia. We studied incident dementia in cognitively healthy participants (aged >45 years) from the community-based Rotterdam Study, an ongoing prospective cohort study based in Rotterdam, the Netherlands, focusing on neurological, cardiovascular, endocrine, and ophthalmological disorders, and other diseases in elderly people. The Rotterdam Study comprises participants in three baseline cohorts (initiated in 1990, 2000, and 2006), who are re-invited to the research centre every 3-4 years, and continuously monitored by records from general practitioners and medical specialists. Cumulative incidence curves up to age 100 years were calculated for Alzheimer's disease and dementia, taking into account mortality as a competing event. These risk curves were stratified by APOE genotypes, tertiles of a weighted genetic risk score (GRS) of 23 Alzheimer's disease-associated genetic variants, and parental history of dementia. 12 255 of 14 926 participants (58·5% women) from the Rotterdam Study were included in this study. During a median follow-up of 11·0 years (IQR 4·9-15·9; 133 123 person years), 1609 participants developed dementia, of whom 1262 (78%) were classified as having Alzheimer's disease; 3310 people died of causes other than dementia. Both APOE and the GRS significantly modified the risks of Alzheimer's disease and dementia. There was evidence for a significant interaction between APOE genotypes and the GRS for the association with Alzheimer's disease (p=0·03) and dementia (p=0·04); the risk for carriers homozygous for APOE ε4 was modified most by the GRS. In carriers homozygous for APOE ε4, the difference between the high-risk tertile and the low-risk tertile by age 85 years was 27·0% for Alzheimer's disease (p=8·5 × 10 ) and 37·2% for dementia (p=2·2 × 10 ), which translates to a 7-10 year difference in age at onset. Comparing the risk extremes, which were carriers homozygous for APOE ε2 or heterozygous with one copy each of the ε2 and ε3 alleles in the low-risk tertile of the GRS versus carriers homozygous for APOE ε4 in the high-risk tertile of the GRS, the difference in risk by age 85 years was 58·6% (4·1% vs 62·7%; p=6·2 × 10 ) for Alzheimer's disease, and 70·3% (7·2% vs 77·5%; p=3·0 × 10 ) for dementia. These risk differences translate into an 18-29 years difference in age at onset for Alzheimer's disease and an 18-23 year difference in age at onset dementia. This difference becomes more pronounced when parental history of dementia is considered (difference in risk 83·8%; p=1·1 × 10 ). Common variants with small individual effects jointly modify the risk and age at onset of Alzheimer's disease and dementia, particularly in APOE ε4 carriers. These findings highlight the potential of common variants in determining Alzheimer's disease risk. None.
Author	Wolters, Frank J van Duijn, Cornelia M Hofman, Albert Ikram, M Arfan Amin, Najaf Ikram, M Kamran van der Lee, Sven J
Author_xml	– sequence: 1 givenname: Sven J surname: van der Lee fullname: van der Lee, Sven J organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands – sequence: 2 givenname: Frank J surname: Wolters fullname: Wolters, Frank J organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands – sequence: 3 givenname: M Kamran surname: Ikram fullname: Ikram, M Kamran organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands – sequence: 4 givenname: Albert surname: Hofman fullname: Hofman, Albert organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands – sequence: 5 givenname: M Arfan surname: Ikram fullname: Ikram, M Arfan organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands – sequence: 6 givenname: Najaf surname: Amin fullname: Amin, Najaf organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands – sequence: 7 givenname: Cornelia M surname: van Duijn fullname: van Duijn, Cornelia M email: c.vanduijn@erasmusmc.nl organization: Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29555425$$D View this record in MEDLINE/PubMed
BookMark	eNqNkcFvFCEUxompse3qn6Ah8WA9TAUGZpkaY5qmtSZNamJNeiMMvHGpM1CBabLe_b9Ld7ce9lJPD977fh_kfftoxwcPCL2m5JAS2nz4TvmcV5wzdkDl-5oQUVfXz9Dept2InX9nxnbRfko3hDDKJX2BdlkrhOBM7KG_VwvA0PdgMg49Pv52eYq1tzjkBURswjgGj3-Ch-wMvtPRaZ8TLr0yLyXBGhv-LMCNEN8lbF0CnWDlYmEEn50-wnrlNXmXl1VXxrbcFyFmnPJkly_R814PCV5t6gz9ODu9OjmvLi6_fD05vqgMZzJX0hrddbRthGnovO4pEZJ0hPd0zruWUymIMS3UXHeyZkTXpJcNEbaXNe80Z_UMHax9b2P4PUHKanTJwDBoD2FKihEqCklbXqRvt6Q3YYq-_K6oGC9brcvKZ-jNRjV1I1h1G92o41I9LrgIPq4FJoaUIvTKuKyzCz5H7QZFiXqIU63iVA9ZKSrVKk51XWixRT8-8BT3ec1BWeadg6iSceANWBdL0soG96TDpy0HMzjvjB5-wfI_-HtCx8mB
CitedBy_id	crossref_primary_10_1093_bib_bbad030 crossref_primary_10_3389_fphar_2024_1415740 crossref_primary_10_3233_JAD_221290 crossref_primary_10_3390_ijms21249441 crossref_primary_10_1016_j_ridd_2020_103638 crossref_primary_10_1016_j_ebiom_2025_105826 crossref_primary_10_31393_reports_vnmedical_2025_29_2__30 crossref_primary_10_1038_s41398_020_01018_7 crossref_primary_10_1016_j_neuropsychologia_2019_107180 crossref_primary_10_1097_MD_0000000000012884 crossref_primary_10_3390_cimb46010060 crossref_primary_10_1007_s12035_025_04970_x crossref_primary_10_1016_j_gim_2024_101082 crossref_primary_10_1212_WNL_0000000000010306 crossref_primary_10_1186_s13024_022_00590_4 crossref_primary_10_1186_s13195_021_00808_5 crossref_primary_10_1016_j_plipres_2023_101256 crossref_primary_10_3390_biomedicines12081888 crossref_primary_10_1021_envhealth_4c00241 crossref_primary_10_1111_ahg_12554 crossref_primary_10_1002_alz_12211 crossref_primary_10_1007_s40520_025_03001_y crossref_primary_10_3389_fnins_2019_00659 crossref_primary_10_1080_13854046_2024_2344869 crossref_primary_10_1186_s13195_021_00895_4 crossref_primary_10_1212_WNL_0000000000213679 crossref_primary_10_1038_s41380_020_0764_y crossref_primary_10_1038_s41572_021_00269_y crossref_primary_10_1093_brain_awac354 crossref_primary_10_1186_s12979_024_00445_0 crossref_primary_10_1002_ana_25501 crossref_primary_10_1002_iid3_1037 crossref_primary_10_1186_s13195_020_00643_0 crossref_primary_10_1038_s41380_023_02076_1 crossref_primary_10_1001_jamanetworkopen_2020_18221 crossref_primary_10_1038_s41598_021_92304_x crossref_primary_10_3390_cells11121963 crossref_primary_10_3390_ijerph21050547 crossref_primary_10_1186_s12967_023_04254_9 crossref_primary_10_1186_s13195_025_01749_z crossref_primary_10_1007_s11033_023_09162_1 crossref_primary_10_3389_fneur_2021_610330 crossref_primary_10_3233_JAD_180780 crossref_primary_10_1016_j_biopsych_2023_02_992 crossref_primary_10_1002_advs_202309889 crossref_primary_10_1002_dad2_12142 crossref_primary_10_3390_brainsci12121681 crossref_primary_10_1097_WAD_0000000000000491 crossref_primary_10_1155_2022_9484217 crossref_primary_10_1002_alz_12180 crossref_primary_10_1002_ana_26048 crossref_primary_10_1080_14737175_2021_1923479 crossref_primary_10_1186_s13073_024_01345_0 crossref_primary_10_3390_jpm10030115 crossref_primary_10_1371_journal_pone_0293832 crossref_primary_10_1186_s13195_024_01569_7 crossref_primary_10_2147_CIA_S513320 crossref_primary_10_3233_JAD_210699 crossref_primary_10_1016_j_jalz_2019_05_011 crossref_primary_10_1111_acel_13384 crossref_primary_10_1161_CIRCULATIONAHA_124_068774 crossref_primary_10_1186_s13073_022_01070_6 crossref_primary_10_3233_JAD_221077 crossref_primary_10_1134_S1022795425700425 crossref_primary_10_1136_jnnp_2021_326043 crossref_primary_10_1093_aje_kwaf108 crossref_primary_10_1016_j_jalz_2019_04_005 crossref_primary_10_1016_j_trci_2019_04_001 crossref_primary_10_1016_j_jalz_2019_04_001 crossref_primary_10_1186_s13195_020_00680_9 crossref_primary_10_3389_fnagi_2021_710966 crossref_primary_10_1016_j_neurol_2023_12_006 crossref_primary_10_1016_j_tjpad_2025_100166 crossref_primary_10_1093_brain_awac213 crossref_primary_10_3233_JAD_230156 crossref_primary_10_1186_s12877_023_03972_5 crossref_primary_10_1007_s10654_024_01160_2 crossref_primary_10_1016_S1474_4422_18_30123_6 crossref_primary_10_3390_nu14071494 crossref_primary_10_1002_admi_202300785 crossref_primary_10_1038_s41598_020_72281_3 crossref_primary_10_3233_JAD_230437 crossref_primary_10_1016_j_jalz_2019_07_010 crossref_primary_10_1016_S0140_6736_20_32205_4 crossref_primary_10_1038_s41433_024_03348_y crossref_primary_10_1093_eurheartj_ehaa695 crossref_primary_10_3233_JAD_200264 crossref_primary_10_1002_gps_5535 crossref_primary_10_1001_jamanetworkopen_2020_0094 crossref_primary_10_1016_j_neurobiolaging_2020_11_009 crossref_primary_10_1080_14737175_2025_2506459 crossref_primary_10_1016_j_trci_2019_08_005 crossref_primary_10_1038_s43587_023_00404_2 crossref_primary_10_1093_hmg_ddz187 crossref_primary_10_3233_JAD_180482 crossref_primary_10_1093_eurheartj_ehad293 crossref_primary_10_1016_j_ynirp_2021_100059 crossref_primary_10_1001_jamanetworkopen_2020_31654 crossref_primary_10_1097_WCO_0000000000001242 crossref_primary_10_3389_fnins_2025_1515374 crossref_primary_10_3390_make5020035 crossref_primary_10_1016_j_atherosclerosis_2024_118614 crossref_primary_10_1073_pnas_2408262121 crossref_primary_10_1159_000535869 crossref_primary_10_3390_cells13090745 crossref_primary_10_1136_medethics_2021_107304 crossref_primary_10_3389_fnagi_2023_1110087 crossref_primary_10_3389_fneur_2021_735036 crossref_primary_10_1016_j_neurobiolaging_2022_12_002 crossref_primary_10_1109_JBHI_2020_3006925 crossref_primary_10_1186_s40504_020_00106_2 crossref_primary_10_1136_pn_2024_004241 crossref_primary_10_1038_s41591_024_02931_w crossref_primary_10_1038_s41591_018_0277_2 crossref_primary_10_1186_s13195_023_01277_8 crossref_primary_10_36219_BPI_2024_2_03 crossref_primary_10_1038_s43856_025_00771_4 crossref_primary_10_3390_biom10040503 crossref_primary_10_3390_genes12081247 crossref_primary_10_1111_cns_14160 crossref_primary_10_1016_j_arr_2021_101402 crossref_primary_10_1038_s41398_024_02898_9 crossref_primary_10_1038_s41398_022_02055_0 crossref_primary_10_3233_JAD_220714 crossref_primary_10_1186_s13195_023_01364_w crossref_primary_10_1016_j_mehy_2024_111355 crossref_primary_10_1007_s11357_022_00545_z crossref_primary_10_1038_s41583_021_00533_w crossref_primary_10_1177_13872877251375473 crossref_primary_10_1371_journal_pone_0271611 crossref_primary_10_3389_fimmu_2023_1120495 crossref_primary_10_3389_fnins_2022_1042865 crossref_primary_10_1016_j_arr_2022_101636 crossref_primary_10_1016_j_nbd_2023_106357 crossref_primary_10_4103_0028_3886_329604 crossref_primary_10_1161_ATVBAHA_119_311908 crossref_primary_10_1038_s41398_018_0221_8 crossref_primary_10_7759_cureus_77781 crossref_primary_10_1038_s44400_025_00013_3 crossref_primary_10_1186_s13195_022_01018_3 crossref_primary_10_1038_s41598_021_91867_z crossref_primary_10_3390_nu12103138 crossref_primary_10_1002_alz_13113 crossref_primary_10_1038_s41598_020_65038_5 crossref_primary_10_1016_j_arr_2020_101114 crossref_primary_10_1002_dad2_12229 crossref_primary_10_1177_25424823251329188 crossref_primary_10_1111_jfbc_14426 crossref_primary_10_3390_biomedicines12051053 crossref_primary_10_1002_alz_70099 crossref_primary_10_1186_s13195_024_01542_4 crossref_primary_10_3390_biomedicines11123232 crossref_primary_10_1038_s41591_019_0547_7 crossref_primary_10_1186_s12877_023_03854_w crossref_primary_10_1212_WNL_0000000000011772 crossref_primary_10_3390_ijerph17207475 crossref_primary_10_3390_cells9122581 crossref_primary_10_1007_s10654_020_00640_5 crossref_primary_10_3233_JAD_190643 crossref_primary_10_1016_j_neurol_2022_03_005 crossref_primary_10_3390_ijms24108827 crossref_primary_10_1186_s12974_024_03040_8 crossref_primary_10_1002_dad2_12298 crossref_primary_10_1016_j_neuroimage_2020_117646 crossref_primary_10_1111_cns_14463 crossref_primary_10_1016_j_arr_2024_102595 crossref_primary_10_1089_g4h_2021_0144 crossref_primary_10_3390_biom13030478 crossref_primary_10_1186_s12967_023_04195_3 crossref_primary_10_3390_biom11091261 crossref_primary_10_1038_s12276_024_01282_3 crossref_primary_10_1007_s00401_019_02026_8 crossref_primary_10_3390_neurolint17070099 crossref_primary_10_1002_acn3_51339 crossref_primary_10_1007_s00702_025_02979_z crossref_primary_10_1186_s13195_018_0406_7 crossref_primary_10_3389_fneur_2021_763573 crossref_primary_10_3233_JAD_220334 crossref_primary_10_1007_s10354_021_00819_9 crossref_primary_10_1002_alz_12122 crossref_primary_10_1038_s41380_024_02685_4 crossref_primary_10_1007_s00415_025_12960_1 crossref_primary_10_1016_j_addr_2022_114398 crossref_primary_10_1016_j_ibneur_2023_09_006 crossref_primary_10_1001_jamanetworkopen_2022_47162 crossref_primary_10_1038_s41467_021_22491_8 crossref_primary_10_1080_13854046_2021_1940299 crossref_primary_10_3233_JAD_191292 crossref_primary_10_1080_19336896_2022_2035479
Cites_doi	10.1016/j.jalz.2016.03.001 10.3233/JAD-150749 10.1093/biomet/74.4.883 10.1093/brain/awv268 10.1001/jamaneurol.2014.1491 10.1056/NEJMoa1211851 10.1097/01.GIM.0000132679.92238.58 10.1056/NEJMoa1211103 10.1016/j.annepidem.2007.03.013 10.3233/JAD-2011-0059 10.1212/WNL.46.3.673 10.1038/mp.2015.23 10.1016/j.jalz.2014.05.1757 10.1001/archneur.1995.00540350068018 10.1186/alzrt213 10.1038/ng.801 10.1161/CIRCULATIONAHA.115.015489 10.1093/hmg/ddu334 10.1212/WNL.43.8.1467 10.1038/ng.2802 10.1007/s10654-017-0321-4 10.1038/ng.440 10.1038/mp.2016.18 10.1016/S1474-4422(12)70291-0 10.18637/jss.v038.i04 10.1080/01621459.1958.10501452 10.1038/mp.2011.52 10.1016/j.jalz.2015.02.013 10.1016/j.reprotox.2008.06.006 10.1016/j.jalz.2014.12.008 10.1001/jama.2010.574 10.1038/ng.3643 10.1007/s00702-012-0920-x 10.1016/S1474-4422(07)70291-0 10.1038/ncomms15842 10.1186/s12916-015-0377-5 10.1097/WAD.0000000000000137 10.1161/01.STR.0000199613.38911.b2 10.1038/nrneurol.2012.263 10.1016/j.neurobiolaging.2013.08.011 10.1212/WNL.0b013e3182553be6 10.1038/ng.439 10.1038/nprot.2015.077 10.1212/WNL.0000000000003871 10.1001/jama.1997.03550160069041 10.1371/journal.pmed.1002258 10.1038/ng.803 10.1093/ije/dyt034 10.1016/j.neurobiolaging.2015.10.028 10.1001/archpsyc.63.2.168 10.1212/WNL.49.6.1498
ContentType	Journal Article
Copyright	2018 Elsevier Ltd Copyright © 2018 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited May 2018
Copyright_xml	– notice: 2018 Elsevier Ltd – notice: Copyright © 2018 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited May 2018
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TK 7X7 7XB 88E 88G 8AO 8C2 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PSYQQ Q9U 7X8
DOI	10.1016/S1474-4422(18)30053-X
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Neurosciences Abstracts ProQuest Health & Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Lancet Titles ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest One Psychology MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1474-4465
EndPage	444
ExternalDocumentID	29555425 10_1016_S1474_4422_18_30053_X S147444221830053X
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	Netherlands
GeographicLocations_xml	– name: Netherlands
GrantInformation	None.
GroupedDBID	--- --K --M -RU .1- .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 8AO 8C2 8FI 8FJ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABIVO ABJNI ABMAC ABMZM ABOCM ABTEW ABUWG ABWVN ACGFS ACIEU ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEVXI AFKRA AFPUW AFRHN AFTJW AFXIZ AGHFR AGWIK AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP AXJTR AZQEC BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ HF~ HMCUK HVGLF HZ~ IHE J1W JCF KOM M1P M2M M41 MO0 N9A NAPCQ O-L O9- OP~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PSYQQ ROL RPZ SDG SEL SES SPCBC SSH SSN SSZ T5K TLN UHS UKHRP UV1 WOW XBR Z5R ~HD 3V. AACTN AADPK ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW RIG SDF ZA5 9DU AAYXX AFFHD CITATION AFCTW ALIPV CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 PUEGO
ID	FETCH-LOGICAL-c428t-8dcabb1965c6173f10580b04f174b941850cc9e34ab8320a30f8605df834ba423
IEDL.DBID	BENPR
ISSN	1474-4422 1474-4465
IngestDate	Wed Oct 01 09:17:36 EDT 2025 Sun Nov 30 04:48:45 EST 2025 Thu Apr 03 07:01:17 EDT 2025 Sat Nov 29 06:59:10 EST 2025 Tue Nov 18 22:26:00 EST 2025 Fri Feb 23 02:28:57 EST 2024 Tue Oct 14 19:33:14 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	5
Language	English
License	Copyright © 2018 Elsevier Ltd. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c428t-8dcabb1965c6173f10580b04f174b941850cc9e34ab8320a30f8605df834ba423
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
PMID	29555425
PQID	2024442305
PQPubID	26255
PageCount	11
ParticipantIDs	proquest_miscellaneous_2015832194 proquest_journals_2024442305 pubmed_primary_29555425 crossref_citationtrail_10_1016_S1474_4422_18_30053_X crossref_primary_10_1016_S1474_4422_18_30053_X elsevier_sciencedirect_doi_10_1016_S1474_4422_18_30053_X elsevier_clinicalkey_doi_10_1016_S1474_4422_18_30053_X
PublicationCentury	2000
PublicationDate	May 2018 2018-05-00 20180501
PublicationDateYYYYMMDD	2018-05-01
PublicationDate_xml	– month: 05 year: 2018 text: May 2018
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	Lancet neurology
PublicationTitleAlternate	Lancet Neurol
PublicationYear	2018
Publisher	Elsevier Ltd Elsevier Limited
Publisher_xml	– name: Elsevier Ltd – name: Elsevier Limited
References	Galea, Tracy (bib42) 2007; 17 Seshadri, Wolf (bib40) 2007; 6 Seshadri, Wolf, Beiser (bib27) 1997; 49 bib33 de Bruijn, Bos, Portegies (bib30) 2015; 13 Harold, Abraham, Hollingworth (bib19) 2009; 41 Seshadri, Beiser, Kelly-Hayes (bib49) 2006; 37 Seshadri, Fitzpatrick, Ikram (bib16) 2010; 303 Ikram, Brusselle, Murad (bib29) 2017; 32 Khan, Shah, Prieto (bib51) 2013; 42 Bras, Guerreiro, Darwent (bib50) 2014; 23 Marden, Mayeda, Walter (bib43) 2016; 30 Genin, Hannequin, Wallon (bib4) 2011; 16 Kaplan, Meier (bib37) 1958; 53 Cupples, Farrer, Sadovnick, Relkin, Whitehouse, Green (bib48) 2004; 6 Desikan, Fan, Wang (bib23) 2017; 14 McCarthy, Das, Kretzschmar (bib34) 2016; 48 Ruiz, Dols-Icardo, Bullido (bib18) 2014; 35 Seshadri, Drachman, Lippa (bib5) 1995; 52 Reiman, Langbaum, Fleisher (bib7) 2011; 26 Sleegers, Bettens, De Roeck (bib20) 2015; 11 Tsai, Jewell, Wang (bib38) 1987; 74 Jack, Knopman, Jagust (bib8) 2013; 12 Naj, Jun, Reitz (bib53) 2014; 71 (bib39) 2016; 12 Lacour, Espinosa, Louwersheimer (bib26) 2017; 22 Meister, Schaefer (bib36) 2008; 26 Naj, Jun, Beecham (bib13) 2011; 43 Moulder, Snider, Mills (bib6) 2013; 5 Allignol, Schumacher, Beyersmann (bib35) 2011; 38 Jun, Ibrahim-Verbaas, Vronskaya (bib15) 2016; 21 Guerreiro, Escott-Price, Darwent (bib52) 2016; 38 Farrer, Cupples, Haines (bib3) 1997; 278 Hollingworth, Harold, Sims (bib10) 2011; 43 Guerreiro, Wojtas, Bras (bib12) 2013; 368 Desikan, Schork, Wang (bib14) 2015; 131 Bickeboller, Campion, Brice (bib47) 1997; 60 Chouraki, Reitz, Maury (bib21) 2016; 53 Schrijvers, Verhaaren, Koudstaal, Hofman, Ikram, Breteler (bib31) 2012; 78 Rodriguez-Rodriguez, Sanchez-Juan, Vazquez-Higuera (bib24) 2013; 120 Saunders, Strittmatter, Schmechel (bib2) 1993; 43 Lambert, Ibrahim-Verbaas, Harold (bib11) 2013; 45 Gatz, Reynolds, Fratiglioni (bib1) 2006; 63 Jonsson, Stefansson, Steinberg (bib17) 2013; 368 Adams, de Bruijn, Hofman (bib25) 2015; 11 Wolters, van der Lee, Koudstaal (bib28) 2017; 88 Liu, Kanekiyo, Xu, Bu (bib45) 2013; 9 van Leeuwen, Kanterakis, Deelen (bib32) 2015; 10 Myers, Schaefer, Wilson (bib46) 1996; 46 Lambert, Heath, Even (bib9) 2009; 41 McDaid, Joshi, Porcu (bib41) 2017; 8 (bib44) 2015; 11 Escott-Price, Sims, Bannister (bib22) 2015; 138 Seshadri (10.1016/S1474-4422(18)30053-X_bib5) 1995; 52 Jack (10.1016/S1474-4422(18)30053-X_bib8) 2013; 12 (10.1016/S1474-4422(18)30053-X_bib39) 2016; 12 Bickeboller (10.1016/S1474-4422(18)30053-X_bib47) 1997; 60 Galea (10.1016/S1474-4422(18)30053-X_bib42) 2007; 17 Ruiz (10.1016/S1474-4422(18)30053-X_bib18) 2014; 35 McCarthy (10.1016/S1474-4422(18)30053-X_bib34) 2016; 48 Jonsson (10.1016/S1474-4422(18)30053-X_bib17) 2013; 368 Guerreiro (10.1016/S1474-4422(18)30053-X_bib12) 2013; 368 Kaplan (10.1016/S1474-4422(18)30053-X_bib37) 1958; 53 Seshadri (10.1016/S1474-4422(18)30053-X_bib49) 2006; 37 Ikram (10.1016/S1474-4422(18)30053-X_bib29) 2017; 32 Farrer (10.1016/S1474-4422(18)30053-X_bib3) 1997; 278 Hollingworth (10.1016/S1474-4422(18)30053-X_bib10) 2011; 43 Lambert (10.1016/S1474-4422(18)30053-X_bib11) 2013; 45 Naj (10.1016/S1474-4422(18)30053-X_bib13) 2011; 43 Jun (10.1016/S1474-4422(18)30053-X_bib15) 2016; 21 Harold (10.1016/S1474-4422(18)30053-X_bib19) 2009; 41 Guerreiro (10.1016/S1474-4422(18)30053-X_bib52) 2016; 38 Desikan (10.1016/S1474-4422(18)30053-X_bib14) 2015; 131 Wolters (10.1016/S1474-4422(18)30053-X_bib28) 2017; 88 Myers (10.1016/S1474-4422(18)30053-X_bib46) 1996; 46 Escott-Price (10.1016/S1474-4422(18)30053-X_bib22) 2015; 138 Allignol (10.1016/S1474-4422(18)30053-X_bib35) 2011; 38 Tsai (10.1016/S1474-4422(18)30053-X_bib38) 1987; 74 Saunders (10.1016/S1474-4422(18)30053-X_bib2) 1993; 43 Sleegers (10.1016/S1474-4422(18)30053-X_bib20) 2015; 11 Lambert (10.1016/S1474-4422(18)30053-X_bib9) 2009; 41 Chouraki (10.1016/S1474-4422(18)30053-X_bib21) 2016; 53 Bras (10.1016/S1474-4422(18)30053-X_bib50) 2014; 23 Khan (10.1016/S1474-4422(18)30053-X_bib51) 2013; 42 Naj (10.1016/S1474-4422(18)30053-X_bib53) 2014; 71 McDaid (10.1016/S1474-4422(18)30053-X_bib41) 2017; 8 Rodriguez-Rodriguez (10.1016/S1474-4422(18)30053-X_bib24) 2013; 120 Cupples (10.1016/S1474-4422(18)30053-X_bib48) 2004; 6 Moulder (10.1016/S1474-4422(18)30053-X_bib6) 2013; 5 de Bruijn (10.1016/S1474-4422(18)30053-X_bib30) 2015; 13 Desikan (10.1016/S1474-4422(18)30053-X_bib23) 2017; 14 Gatz (10.1016/S1474-4422(18)30053-X_bib1) 2006; 63 Seshadri (10.1016/S1474-4422(18)30053-X_bib27) 1997; 49 Liu (10.1016/S1474-4422(18)30053-X_bib45) 2013; 9 Adams (10.1016/S1474-4422(18)30053-X_bib25) 2015; 11 Meister (10.1016/S1474-4422(18)30053-X_bib36) 2008; 26 Seshadri (10.1016/S1474-4422(18)30053-X_bib40) 2007; 6 (10.1016/S1474-4422(18)30053-X_bib44) 2015; 11 Reiman (10.1016/S1474-4422(18)30053-X_bib7) 2011; 26 Lacour (10.1016/S1474-4422(18)30053-X_bib26) 2017; 22 Seshadri (10.1016/S1474-4422(18)30053-X_bib16) 2010; 303 van Leeuwen (10.1016/S1474-4422(18)30053-X_bib32) 2015; 10 Genin (10.1016/S1474-4422(18)30053-X_bib4) 2011; 16 Marden (10.1016/S1474-4422(18)30053-X_bib43) 2016; 30 Schrijvers (10.1016/S1474-4422(18)30053-X_bib31) 2012; 78 29705249 - Lancet Neurol. 2018 Apr 25 29656734 - Lancet Neurol. 2018 May;17(5):388-389
References_xml	– volume: 26 start-page: 31 year: 2008 end-page: 35 ident: bib36 article-title: Statistical methods for estimating the probability of spontaneous abortion in observational studies—analyzing pregnancies exposed to coumarin derivatives publication-title: Reprod Toxicol – volume: 12 start-page: 459 year: 2016 end-page: 509 ident: bib39 article-title: 2016 Alzheimer's disease facts and figures publication-title: Alzheimers Dement – volume: 368 start-page: 107 year: 2013 end-page: 116 ident: bib17 article-title: Variant of TREM2 associated with the risk of Alzheimer's disease publication-title: N Engl J Med – volume: 38 start-page: 214.e7 year: 2016 end-page: 214.e10 ident: bib52 article-title: Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases publication-title: Neurobiol Aging – volume: 12 start-page: 207 year: 2013 end-page: 216 ident: bib8 article-title: Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers publication-title: Lancet Neurol – volume: 52 start-page: 1074 year: 1995 end-page: 1079 ident: bib5 article-title: Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know publication-title: Arch Neurol – volume: 6 start-page: 1106 year: 2007 end-page: 1114 ident: bib40 article-title: Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study publication-title: Lancet Neurol – volume: 9 start-page: 106 year: 2013 end-page: 118 ident: bib45 article-title: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy publication-title: Nat Rev Neurol – volume: 48 start-page: 1279 year: 2016 end-page: 1283 ident: bib34 article-title: A reference panel of 64,976 haplotypes for genotype imputation publication-title: Nat Genet – volume: 26 start-page: 321 year: 2011 end-page: 329 ident: bib7 article-title: Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments publication-title: J Alzheimers Dis – volume: 11 start-page: 658 year: 2015 end-page: 671 ident: bib44 article-title: Convergent genetic and expression data implicate immunity in Alzheimer's disease publication-title: Alzheimers Dement – volume: 13 start-page: 132 year: 2015 ident: bib30 article-title: The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study publication-title: BMC Med – volume: 32 start-page: 807 year: 2017 end-page: 850 ident: bib29 article-title: The Rotterdam Study: 2018 update on objectives, design and main results publication-title: Eur J Epidemiol – volume: 131 start-page: 2061 year: 2015 end-page: 2069 ident: bib14 article-title: Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease publication-title: Circulation – volume: 5 start-page: 48 year: 2013 ident: bib6 article-title: Dominantly Inherited Alzheimer Network: facilitating research and clinical trials publication-title: Alzheimers Res Ther – volume: 53 start-page: 921 year: 2016 end-page: 932 ident: bib21 article-title: Evaluation of a genetic risk score to improve risk prediction for Alzheimer's disease publication-title: J Alzheimers Dis – volume: 10 start-page: 1285 year: 2015 end-page: 1296 ident: bib32 article-title: Population-specific genotype imputations using minimac or IMPUTE2 publication-title: Nat Protoc – volume: 30 start-page: 195 year: 2016 end-page: 202 ident: bib43 article-title: Using an Alzheimer disease polygenic risk score to predict memory decline in black and white Americans over 14 years of follow-up publication-title: Alzheimer Dis Assoc Disord – volume: 11 start-page: 1277 year: 2015 end-page: 1285 ident: bib25 article-title: Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia publication-title: Alzheimers Dement – ident: bib33 article-title: HRC or 1000G Imputation preparation and checking – volume: 138 start-page: 3673 year: 2015 end-page: 3684 ident: bib22 article-title: Common polygenic variation enhances risk prediction for Alzheimer's disease publication-title: Brain – volume: 43 start-page: 429 year: 2011 end-page: 435 ident: bib10 article-title: Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease publication-title: Nat Genet – volume: 120 start-page: 807 year: 2013 end-page: 812 ident: bib24 article-title: Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease publication-title: J Neural Transm (Vienna) – volume: 368 start-page: 117 year: 2013 end-page: 127 ident: bib12 article-title: TREM2 variants in Alzheimer's disease publication-title: N Engl J Med – volume: 35 start-page: 444.e1 year: 2014 end-page: 444.e4 ident: bib18 article-title: Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia publication-title: Neurobiol Aging – volume: 8 start-page: 15842 year: 2017 ident: bib41 article-title: Bayesian association scan reveals loci associated with human lifespan and linked biomarkers publication-title: Nat Commun – volume: 6 start-page: 192 year: 2004 end-page: 196 ident: bib48 article-title: Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study publication-title: Genet Med – volume: 41 start-page: 1094 year: 2009 end-page: 1099 ident: bib9 article-title: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease publication-title: Nat Genet – volume: 63 start-page: 168 year: 2006 end-page: 174 ident: bib1 article-title: Role of genes and environments for explaining Alzheimer disease publication-title: Arch Gen Psychiatry – volume: 49 start-page: 1498 year: 1997 end-page: 1504 ident: bib27 article-title: Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study publication-title: Neurology – volume: 46 start-page: 673 year: 1996 end-page: 677 ident: bib46 article-title: Apolipoprotein E epsilon4 association with dementia in a population-based study: the Framingham study publication-title: Neurology – volume: 41 start-page: 1088 year: 2009 end-page: 1093 ident: bib19 article-title: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease publication-title: Nat Genet – volume: 53 start-page: 457 year: 1958 end-page: 481 ident: bib37 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc – volume: 88 start-page: 1642 year: 2017 end-page: 1649 ident: bib28 article-title: Parental family history of dementia in relation to subclinical brain disease and dementia risk publication-title: Neurology – volume: 303 start-page: 1832 year: 2010 end-page: 1840 ident: bib16 article-title: Genome-wide analysis of genetic loci associated with Alzheimer disease publication-title: JAMA – volume: 17 start-page: 643 year: 2007 end-page: 653 ident: bib42 article-title: Participation rates in epidemiologic studies publication-title: Ann Epidemiol – volume: 278 start-page: 1349 year: 1997 end-page: 1356 ident: bib3 article-title: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. publication-title: JAMA – volume: 14 start-page: e1002258 year: 2017 ident: bib23 article-title: Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score publication-title: PLoS Med – volume: 78 start-page: 1456 year: 2012 end-page: 1463 ident: bib31 article-title: Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study publication-title: Neurology – volume: 74 start-page: 883 year: 1987 end-page: 886 ident: bib38 article-title: A Note on the product-limit estimator under right censoring and left truncation publication-title: Biometrika – volume: 43 start-page: 1467 year: 1993 end-page: 1472 ident: bib2 article-title: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease publication-title: Neurology – volume: 45 start-page: 1452 year: 2013 end-page: 1458 ident: bib11 article-title: Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease publication-title: Nat Genet – volume: 37 start-page: 345 year: 2006 end-page: 350 ident: bib49 article-title: The lifetime risk of stroke: estimates from the Framingham Study publication-title: Stroke – volume: 42 start-page: 475 year: 2013 end-page: 492 ident: bib51 article-title: Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals publication-title: Int J Epidemiol – volume: 22 start-page: 153 year: 2017 end-page: 160 ident: bib26 article-title: Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment publication-title: Mol Psychiatry – volume: 60 start-page: 439 year: 1997 end-page: 446 ident: bib47 article-title: Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex publication-title: Am J Hum Genet – volume: 71 start-page: 1394 year: 2014 end-page: 1404 ident: bib53 article-title: Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study publication-title: JAMA Neurol – volume: 43 start-page: 436 year: 2011 end-page: 441 ident: bib13 article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease publication-title: Nat Genet – volume: 21 start-page: 108 year: 2016 end-page: 117 ident: bib15 article-title: A novel Alzheimer disease locus located near the gene encoding tau protein publication-title: Mol Psychiatry – volume: 23 start-page: 6139 year: 2014 end-page: 6146 ident: bib50 article-title: Genetic analysis implicates publication-title: Hum Mol Genet – volume: 11 start-page: 1452 year: 2015 end-page: 1460 ident: bib20 article-title: A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Abeta42 publication-title: Alzheimers Dement – volume: 16 start-page: 903 year: 2011 end-page: 907 ident: bib4 article-title: and Alzheimer disease: a major gene with semi-dominant inheritance publication-title: Mol Psychiatry – volume: 38 start-page: 1 year: 2011 end-page: 15 ident: bib35 article-title: Empirical transition matrix of multi-state models: the etm package publication-title: J Stat Softw – volume: 12 start-page: 459 year: 2016 ident: 10.1016/S1474-4422(18)30053-X_bib39 article-title: 2016 Alzheimer's disease facts and figures publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.03.001 – volume: 53 start-page: 921 year: 2016 ident: 10.1016/S1474-4422(18)30053-X_bib21 article-title: Evaluation of a genetic risk score to improve risk prediction for Alzheimer's disease publication-title: J Alzheimers Dis doi: 10.3233/JAD-150749 – volume: 74 start-page: 883 year: 1987 ident: 10.1016/S1474-4422(18)30053-X_bib38 article-title: A Note on the product-limit estimator under right censoring and left truncation publication-title: Biometrika doi: 10.1093/biomet/74.4.883 – volume: 138 start-page: 3673 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib22 article-title: Common polygenic variation enhances risk prediction for Alzheimer's disease publication-title: Brain doi: 10.1093/brain/awv268 – volume: 71 start-page: 1394 year: 2014 ident: 10.1016/S1474-4422(18)30053-X_bib53 article-title: Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2014.1491 – volume: 368 start-page: 117 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib12 article-title: TREM2 variants in Alzheimer's disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1211851 – volume: 6 start-page: 192 year: 2004 ident: 10.1016/S1474-4422(18)30053-X_bib48 article-title: Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study publication-title: Genet Med doi: 10.1097/01.GIM.0000132679.92238.58 – volume: 368 start-page: 107 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib17 article-title: Variant of TREM2 associated with the risk of Alzheimer's disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1211103 – volume: 17 start-page: 643 year: 2007 ident: 10.1016/S1474-4422(18)30053-X_bib42 article-title: Participation rates in epidemiologic studies publication-title: Ann Epidemiol doi: 10.1016/j.annepidem.2007.03.013 – volume: 26 start-page: 321 issue: suppl 3 year: 2011 ident: 10.1016/S1474-4422(18)30053-X_bib7 article-title: Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments publication-title: J Alzheimers Dis doi: 10.3233/JAD-2011-0059 – volume: 46 start-page: 673 year: 1996 ident: 10.1016/S1474-4422(18)30053-X_bib46 article-title: Apolipoprotein E epsilon4 association with dementia in a population-based study: the Framingham study publication-title: Neurology doi: 10.1212/WNL.46.3.673 – volume: 21 start-page: 108 year: 2016 ident: 10.1016/S1474-4422(18)30053-X_bib15 article-title: A novel Alzheimer disease locus located near the gene encoding tau protein publication-title: Mol Psychiatry doi: 10.1038/mp.2015.23 – volume: 11 start-page: 658 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib44 article-title: Convergent genetic and expression data implicate immunity in Alzheimer's disease publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2014.05.1757 – volume: 52 start-page: 1074 year: 1995 ident: 10.1016/S1474-4422(18)30053-X_bib5 article-title: Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know publication-title: Arch Neurol doi: 10.1001/archneur.1995.00540350068018 – volume: 5 start-page: 48 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib6 article-title: Dominantly Inherited Alzheimer Network: facilitating research and clinical trials publication-title: Alzheimers Res Ther doi: 10.1186/alzrt213 – volume: 43 start-page: 436 year: 2011 ident: 10.1016/S1474-4422(18)30053-X_bib13 article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease publication-title: Nat Genet doi: 10.1038/ng.801 – volume: 131 start-page: 2061 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib14 article-title: Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.015489 – volume: 23 start-page: 6139 year: 2014 ident: 10.1016/S1474-4422(18)30053-X_bib50 article-title: Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies publication-title: Hum Mol Genet doi: 10.1093/hmg/ddu334 – volume: 43 start-page: 1467 year: 1993 ident: 10.1016/S1474-4422(18)30053-X_bib2 article-title: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease publication-title: Neurology doi: 10.1212/WNL.43.8.1467 – volume: 45 start-page: 1452 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib11 article-title: Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease publication-title: Nat Genet doi: 10.1038/ng.2802 – volume: 32 start-page: 807 year: 2017 ident: 10.1016/S1474-4422(18)30053-X_bib29 article-title: The Rotterdam Study: 2018 update on objectives, design and main results publication-title: Eur J Epidemiol doi: 10.1007/s10654-017-0321-4 – volume: 41 start-page: 1088 year: 2009 ident: 10.1016/S1474-4422(18)30053-X_bib19 article-title: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease publication-title: Nat Genet doi: 10.1038/ng.440 – volume: 22 start-page: 153 year: 2017 ident: 10.1016/S1474-4422(18)30053-X_bib26 article-title: Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment publication-title: Mol Psychiatry doi: 10.1038/mp.2016.18 – volume: 12 start-page: 207 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib8 article-title: Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70291-0 – volume: 38 start-page: 1 year: 2011 ident: 10.1016/S1474-4422(18)30053-X_bib35 article-title: Empirical transition matrix of multi-state models: the etm package publication-title: J Stat Softw doi: 10.18637/jss.v038.i04 – volume: 53 start-page: 457 year: 1958 ident: 10.1016/S1474-4422(18)30053-X_bib37 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc doi: 10.1080/01621459.1958.10501452 – volume: 16 start-page: 903 year: 2011 ident: 10.1016/S1474-4422(18)30053-X_bib4 article-title: APOE and Alzheimer disease: a major gene with semi-dominant inheritance publication-title: Mol Psychiatry doi: 10.1038/mp.2011.52 – volume: 11 start-page: 1452 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib20 article-title: A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Abeta42 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2015.02.013 – volume: 26 start-page: 31 year: 2008 ident: 10.1016/S1474-4422(18)30053-X_bib36 article-title: Statistical methods for estimating the probability of spontaneous abortion in observational studies—analyzing pregnancies exposed to coumarin derivatives publication-title: Reprod Toxicol doi: 10.1016/j.reprotox.2008.06.006 – volume: 60 start-page: 439 year: 1997 ident: 10.1016/S1474-4422(18)30053-X_bib47 article-title: Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex publication-title: Am J Hum Genet – volume: 11 start-page: 1277 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib25 article-title: Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2014.12.008 – volume: 303 start-page: 1832 year: 2010 ident: 10.1016/S1474-4422(18)30053-X_bib16 article-title: Genome-wide analysis of genetic loci associated with Alzheimer disease publication-title: JAMA doi: 10.1001/jama.2010.574 – volume: 48 start-page: 1279 year: 2016 ident: 10.1016/S1474-4422(18)30053-X_bib34 article-title: A reference panel of 64,976 haplotypes for genotype imputation publication-title: Nat Genet doi: 10.1038/ng.3643 – volume: 120 start-page: 807 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib24 article-title: Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease publication-title: J Neural Transm (Vienna) doi: 10.1007/s00702-012-0920-x – volume: 6 start-page: 1106 year: 2007 ident: 10.1016/S1474-4422(18)30053-X_bib40 article-title: Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(07)70291-0 – volume: 8 start-page: 15842 year: 2017 ident: 10.1016/S1474-4422(18)30053-X_bib41 article-title: Bayesian association scan reveals loci associated with human lifespan and linked biomarkers publication-title: Nat Commun doi: 10.1038/ncomms15842 – volume: 13 start-page: 132 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib30 article-title: The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study publication-title: BMC Med doi: 10.1186/s12916-015-0377-5 – volume: 30 start-page: 195 year: 2016 ident: 10.1016/S1474-4422(18)30053-X_bib43 article-title: Using an Alzheimer disease polygenic risk score to predict memory decline in black and white Americans over 14 years of follow-up publication-title: Alzheimer Dis Assoc Disord doi: 10.1097/WAD.0000000000000137 – volume: 37 start-page: 345 year: 2006 ident: 10.1016/S1474-4422(18)30053-X_bib49 article-title: The lifetime risk of stroke: estimates from the Framingham Study publication-title: Stroke doi: 10.1161/01.STR.0000199613.38911.b2 – volume: 9 start-page: 106 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib45 article-title: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2012.263 – volume: 35 start-page: 444.e1 year: 2014 ident: 10.1016/S1474-4422(18)30053-X_bib18 article-title: Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.08.011 – volume: 78 start-page: 1456 year: 2012 ident: 10.1016/S1474-4422(18)30053-X_bib31 article-title: Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study publication-title: Neurology doi: 10.1212/WNL.0b013e3182553be6 – volume: 41 start-page: 1094 year: 2009 ident: 10.1016/S1474-4422(18)30053-X_bib9 article-title: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease publication-title: Nat Genet doi: 10.1038/ng.439 – volume: 10 start-page: 1285 year: 2015 ident: 10.1016/S1474-4422(18)30053-X_bib32 article-title: Population-specific genotype imputations using minimac or IMPUTE2 publication-title: Nat Protoc doi: 10.1038/nprot.2015.077 – volume: 88 start-page: 1642 year: 2017 ident: 10.1016/S1474-4422(18)30053-X_bib28 article-title: Parental family history of dementia in relation to subclinical brain disease and dementia risk publication-title: Neurology doi: 10.1212/WNL.0000000000003871 – volume: 278 start-page: 1349 year: 1997 ident: 10.1016/S1474-4422(18)30053-X_bib3 article-title: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium publication-title: JAMA doi: 10.1001/jama.1997.03550160069041 – volume: 14 start-page: e1002258 year: 2017 ident: 10.1016/S1474-4422(18)30053-X_bib23 article-title: Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score publication-title: PLoS Med doi: 10.1371/journal.pmed.1002258 – volume: 43 start-page: 429 year: 2011 ident: 10.1016/S1474-4422(18)30053-X_bib10 article-title: Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease publication-title: Nat Genet doi: 10.1038/ng.803 – volume: 42 start-page: 475 year: 2013 ident: 10.1016/S1474-4422(18)30053-X_bib51 article-title: Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals publication-title: Int J Epidemiol doi: 10.1093/ije/dyt034 – volume: 38 start-page: 214.e7 year: 2016 ident: 10.1016/S1474-4422(18)30053-X_bib52 article-title: Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2015.10.028 – volume: 63 start-page: 168 year: 2006 ident: 10.1016/S1474-4422(18)30053-X_bib1 article-title: Role of genes and environments for explaining Alzheimer disease publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.2.168 – volume: 49 start-page: 1498 year: 1997 ident: 10.1016/S1474-4422(18)30053-X_bib27 article-title: Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study publication-title: Neurology doi: 10.1212/WNL.49.6.1498 – reference: 29705249 - Lancet Neurol. 2018 Apr 25;: – reference: 29656734 - Lancet Neurol. 2018 May;17(5):388-389
SSID	ssj0021481
Score	2.6202557
Snippet	Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major genetic determinant... Summary Background Alzheimer's disease is one of the most heritable diseases in elderly people and the most common type of dementia. In addition to the major...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	434
SubjectTerms	Age Age of Onset Aged Aged, 80 and over Alzheimer Disease - epidemiology Alzheimer Disease - genetics Alzheimer's disease Apolipoprotein E Apolipoproteins E - genetics Blood pressure Cohort analysis Cohort Studies Dementia Dementia - epidemiology Dementia - genetics Dementia disorders Female Genetic diversity Genotypes Geriatrics Health risk assessment Humans Male Middle Aged Netherlands - epidemiology Neurodegenerative diseases Risk Assessment - statistics & numerical data Risk factors Studies Vitamin E
Title	The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S147444221830053X https://dx.doi.org/10.1016/S1474-4422(18)30053-X https://www.ncbi.nlm.nih.gov/pubmed/29555425 https://www.proquest.com/docview/2024442305 https://www.proquest.com/docview/2015832194
Volume	17
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-4465 dateEnd: 20251007 omitProxy: false ssIdentifier: ssj0021481 issn: 1474-4422 databaseCode: 7RV dateStart: 20020501 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central - New (Subscription) customDbUrl: eissn: 1474-4465 dateEnd: 20251007 omitProxy: false ssIdentifier: ssj0021481 issn: 1474-4422 databaseCode: BENPR dateStart: 20020501 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1474-4465 dateEnd: 20251007 omitProxy: false ssIdentifier: ssj0021481 issn: 1474-4422 databaseCode: 7X7 dateStart: 20020501 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-4465 dateEnd: 20251007 omitProxy: false ssIdentifier: ssj0021481 issn: 1474-4422 databaseCode: M2M dateStart: 20020501 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLUJceEMXSmUkJOBgyMbexOGCCtqKyy6r8lBuluPYYqU2W_ZRCe78b2YcJz2VInGJlMdMHjOZ-cYezwA8F1ZmynnLXe48lzK13KRyzNGbGJtZJ721odlEPpupsizmccBtHdMqO5sYDHW9tDRGTkG6RFaonu_OfnDqGkWzq7GFxg7sUqUyOYDd95PZ_LgPuRDsh5BL5pIeJL1Yw_Pmc3_w5Ui9oqrtgpeXeafL0GfwQke3__f578CtiD_ZYaswd-Gaa-7BjWmcYb8Pv1FvWJvkwZaeHc4_TZhpahYWajG8FfJhqHS09pGdY6BNeTQMj-F5RpnZLdnJr-9ucepWL9YsTgEFLnUYjFyYt8wEXls0KD85edKaUave1YaFercP4OvR5MuHjzy2auAW45cNV7U1VUXVCS1CIuERtamkSqTHgKcqqEBOYm3hhDQVmpDEiMQrDKRqr4SsDH6WhzBolo3bA1bXxiOOsanF7yWEKDKL12SVKUZOqNQNQXYi0jbWMad2Gie6T1gjyWqSrB4pHSSryyG87snO2kIeVxFknfx1t0oV7apGV3MVoeoJI4xp4cm_kO53yqOjLVnrC80ZwrP-NFoBmtoxjVtu6ZrRmHpOFXIIj1oF7d8yLcaIGdPx478zfwI3kYtqkzn3YbBZbd1TuG7PN4v16gB28uNvtC3zsFUH8VfDvWk6_QOVbCkE
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBQEX3o-FAkYCAQdDEnuzDhJCFbRq1XapoKC9GcexxUolWzbZonLn7_AbmXEePZVy6YFrkhnFyTy-secB8FhYmSrnLXcj57mUieUmkUOO3sTY1DrprQ3DJkbjsZpMst0l-N3VwlBaZWcTg6EuZpb2yClIl8gKxfPNwXdOU6PodLUbodGIxZY7-oEhW_V68x3-3ydJsr6293aDt1MFuEWoXXNVWJPn1EjPovcWHgGGivJIesTmeUa9XCJrMyekyVHaIyMirxDzF14JmRtJjQ7Q5J9DOx5TCtnow-c-wMPQIgR4ciRp2clxxdDLj_3FZ7F6Tj3iBZ-c5AtPwrrB561f-d--1lW43KJrttqowzVYcuV1uLDT5g_cgF-oFaxJYWEzz1Z3368xUxYslKExXBq-N0OVospOdmhQOcu6YngN7zPKO2_I9n9-ddNvbv60Yu0BV-BShK3WqXnFTOC1QHN5xAknFIwGEc9rFrr53oRPZ_IRbsFyOSvdHWBFYTyiNJtY_D9CiCy1-Eyamyx2QiVuALITCW3bLu00LGRf9-l4JEmaJEnHSgdJ0pMBvOjJDpo2JacRpJ286a4GF72GRkd6GqHqCVuQ1oCvfyFd6YRVt5ay0seSOoBH_W20cXRwZUo3W9Az8ZAmamVyALcbhehXmWRDRMTJ8O7fmT-Eixt7O9t6e3O8dQ8uIUfVpK2uwHI9X7j7cN4e1tNq_iCoNIMvZ60VfwAOEX7L
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqgiouvB9LCxgJBBxMs7aTdZAQqmhXVGWXlQBpb67j2GKlki2bbKty75_qr2PGefRUyqUHrklmlDjz-MaeByEvhJWJct4yN3CeScktM1zGDLyJsYl10lsbhk0MxmM1naaTFXLW1sJgWmVrE4OhzucW98gxSJfACsRz0zdpEZPt4YfDXwwnSOFJaztOoxaRPXdyDOFb-X53G_71S86HO98-fmLNhAFmAXZXTOXWZBk21bPgyYUHsKGiLJIecHqWYl-XyNrUCWkykPzIiMgrwP-5V0JmRmLTAzD_1wYyjnF6woiPumAPwowQ7MmBxCXg59VDm1-7i6_76g32ixdsepFfvAj3Bv83vPU_r9xtcrNB3XSrVpM7ZMUVd8naqMkruEdOQVtondpC555uTb7sUFPkNJSnUfhMeG8KqoYVn_TIgNIWVUnhGtynmI9ekx38_uFmP93iVUmbg6_AJQ9bsDPzjprAawlm9IQhfsgpDiheVDR0-b1Pvl_JIjwgq8W8cI8IzXPjAb1ZbuFfCSHSxMIzSWbSvhOKux6RrXho23RvxyEiB7pL00Op0ihVuq90kCo97ZG3Hdlh3b7kMoKklT3d1uaCN9HgYC8jVB1hA95qUPYvpBut4OrGgpb6XGp75Hl3G2wfHmiZws2X-Ew_xklbqeyRh7VydF_J0xiQMo8f_535M7IGyqA_74731skNYKjqbNYNslotlu4JuW6Pqlm5eBq0m5L9q1aKPyEoh2I
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+APOE+and+other+common+genetic+variants+on+the+onset+of+Alzheimer%27s+disease+and+dementia%3A+a+community-based+cohort+study&rft.jtitle=Lancet+neurology&rft.au=van+der+Lee%2C+Sven+J&rft.au=Wolters%2C+Frank+J&rft.au=Ikram%2C+M+Kamran&rft.au=Hofman%2C+Albert&rft.date=2018-05-01&rft.eissn=1474-4465&rft.volume=17&rft.issue=5&rft.spage=434&rft_id=info:doi/10.1016%2FS1474-4422%2818%2930053-X&rft_id=info%3Apmid%2F29555425&rft.externalDocID=29555425
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1474-4422&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1474-4422&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1474-4422&client=summon